Go to deals
Private Equity | Healthcare

DCN Dx has received a growth equity investment from Martis Capital

DCN Dx, a leading provider of contract development services, has received a growth equity investment from Martis Capital.

DCN Dx offers contract development services for clients seeking to explore, develop and commercialize rapid diagnostic tests related to lateral flow assay. DCN Dx supports an array of customers including global diagnostics manufacturers, nonprofits seeking tests for low-resource settings and start-ups launching diagnostic-based products. Over the past 15 years, DCN Dx has successfully developed more than 100 rapid diagnostic tests for its customers.

Martis Capital is a private equity firm which manages more than US$1.2 billion of equity and is focused exclusively on investing in middle-market growth companies in the healthcare industry.

One of Oaklins’ teams in the USA, together with Pegasus Capital, served as a financial advisor to DCN Dx, in connection with a growth equity investment from Martis Capital.

Service
M&A sell-side
Parties

Talk to the deal team

 Bradford A. Adams

Bradford A. Adams

Managing Director
Boston, United States
Oaklins TM Capital
 Michael S. Goldman

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital
 James  McLaren

James McLaren

Managing Director
New York, United States
Oaklins TM Capital

Related deals

SulAmérica and Rede D’Or São Luiz have announced a combination
Financial Services | Healthcare

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Learn more
Ricotto has been acquired by Sitra Group
Private Equity | Logistics

Ricotto has been acquired by Sitra Group

Ricotto S.r.l. has joint Sitra Group, a Belgium-based and PE-backed international logistic and transportation group.

Learn more
M80 Partners has acquired Luminis
Private Equity | TMT

M80 Partners has acquired Luminis

Belgian private equity fund M80 has acquired a majority stake in Luminis. M80 offers to software and technology company Luminis the opportunity to further expand its strategy and market position internationally. Luminis becomes part of a platform that also includes XPLUS, a Belgian expert in enterprise IT architecture. M80 plans to make further selective acquisitions in Europe in the coming months with the aim of bringing together a portfolio of best-in-class digital transformation specialists.

Learn more